Lucid Diagnostics Inc. (LUCD)
NASDAQ: LUCD · IEX Real-Time Price · USD
0.780
-0.009 (-1.14%)
At close: Jul 2, 2024, 4:00 PM
0.760
-0.020 (-2.55%)
After-hours: Jul 2, 2024, 7:39 PM EDT

Lucid Diagnostics Revenue

Lucid Diagnostics had revenue of $2.98M in the twelve months ending March 31, 2024, with 370.50% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $1.00M with 124.44% year-over-year growth. In the year 2023, Lucid Diagnostics had annual revenue of $2.43M with 544.03% growth.

Revenue (ttm)
$2.98M
Revenue Growth
+370.50%
P/S Ratio
13.71
Revenue / Employee
$42,614
Employees
70
Market Cap
40.89M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20232.43M2.05M544.03%
Dec 31, 2022377.00K-123.00K-24.60%
Dec 31, 2021500.00K--
Dec 31, 20200--
Dec 31, 20190--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Inotiv 552.74M
Augmedix 48.70M
Atara Biotherapeutics 34.70M
Dyadic International 2.26M
vTv Therapeutics 1.00M
Revenue Rankings